Latest filing published 16 Oct 2026 for Akari Therapeutics Plc, €89k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -47.9%Entry US$10.85 · Close at T+365 US$5.65
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert B. Bazemore: trading record in brief
Robert B. Bazemore has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Epizyme, Inc., Akari Therapeutics PLC and Trimeris Inc. The record holds 33 filings, for trades running from 23 September 2014 to 14 October 2026.
On the open market, the record shows 1 purchase worth €43k and 10 sales worth €871k. On balance, insiders were net sellers of €829k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 17 share grants and 3 option exercises.
Most recently, on 16 October 2026, the filings show a share grant worth €33k in Akari Therapeutics PLC. The clock since the last published purchase (1 April 2021) now reads 2,047 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert B. Bazemore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 13,100 shares@ US$7.8990.55% mcap53.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047455:0
- 4,677 shares@ US$7.8990.20% mcap19.5% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047455:1
- 773 shares@ US$0.00040.0000% mcap0.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047455:2
- 3,093 shares@ US$0.00040.0000% mcap0.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0001493152-26-047455:3
- 26,455 sharesCommon StockSEC:0001620152-26-000005:0
- 41,551 shares0Common StockSEC:0001628280-25-032730:0
- 44,642 shares@ US$1.12100.0% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-25-036482:0
- 5,000 shares@ US$9.98100.0% of flowClass A Common StockSEC:0001209191-21-024159:0Canonical exit: 28 Jun 2021 (T+90)
- 10,328 shares@ US$7.858.9% of flowCommon Stock, par value $0.0001SEC:0000899243-21-013804:0
- 3,890 shares@ US$11.214.7% of flowCommon Stock, par value $0.0001SEC:0000899243-21-005044:0
- 87,500 shares0Common StockSEC:0000899243-21-004523:0
- 6,069 shares@ US$11.417.4% of flowCommon Stock, par value $0.0001SEC:0000899243-21-003535:0
- 4,773 shares@ US$16.159.0% of flowCommon Stock, par value $0.0001SEC:0000899243-20-017904:1
- 10,500 sharesCommon Stock, par value $0.0001SEC:0000899243-20-017904:0
- 10,000 shares@ US$8.9810.4% of flowCommon Stock, par value $0.0001SEC:0000899243-20-017444:0
- 10,000 shares@ US$22.0025.6% of flowCommon Stock, par value $0.0001SEC:0000899243-20-017444:1
- 3,285 shares@ US$15.286.1% of flowCommon Stock, par value $0.0001SEC:0000899243-20-009605:3
- 56,537 shares0Common Stock, par value $0.0001SEC:0000899243-20-009605:0
- 113,393 shares0Common Stock, par value $0.0001SEC:0000899243-20-009605:1
- 7,000 shares0Common Stock, par value $0.0001SEC:0000899243-20-009605:2
- 52,595 shares0Common StockSEC:0000899243-20-003376:0
- 8,750 sharesCommon Stock, par value $0.0001SEC:0000899243-20-002113:0
- 3,002 shares@ US$24.6211.3% of flowCommon Stock, par value $0.0001SEC:0000899243-20-002113:1
- 6,074 shares@ US$20.4419.0% of flowCommon Stock, par value $0.0001SEC:0000899243-20-002113:2
- 7,000 sharesCommon Stock, par value $0.0001SEC:0000899243-19-017098:0
25 of 32 declarations
